Skip to main content
Journal cover image

Letter to the Editor: mRNA Vaccines in Urological Malignancies.

Publication ,  Journal Article
Yang, L; Gao, G; Huang, J
Published in: Hum Gene Ther
October 2022

Duke Scholars

Published In

Hum Gene Ther

DOI

EISSN

1557-7422

Publication Date

October 2022

Volume

33

Issue

19-20

Start / End Page

1101 / 1102

Location

United States

Related Subject Headings

  • mRNA Vaccines
  • Vaccines
  • Urologic Neoplasms
  • Immunotherapy
  • Humans
  • Biotechnology
  • 3206 Medical biotechnology
  • 1103 Clinical Sciences
  • 1004 Medical Biotechnology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yang, L., Gao, G., & Huang, J. (2022). Letter to the Editor: mRNA Vaccines in Urological Malignancies. Hum Gene Ther, 33(19–20), 1101–1102. https://doi.org/10.1089/hum.2022.29218.lya
Yang, Lu, Guangping Gao, and Jiaoti Huang. “Letter to the Editor: mRNA Vaccines in Urological Malignancies.Hum Gene Ther 33, no. 19–20 (October 2022): 1101–2. https://doi.org/10.1089/hum.2022.29218.lya.
Yang L, Gao G, Huang J. Letter to the Editor: mRNA Vaccines in Urological Malignancies. Hum Gene Ther. 2022 Oct;33(19–20):1101–2.
Yang, Lu, et al. “Letter to the Editor: mRNA Vaccines in Urological Malignancies.Hum Gene Ther, vol. 33, no. 19–20, Oct. 2022, pp. 1101–02. Pubmed, doi:10.1089/hum.2022.29218.lya.
Yang L, Gao G, Huang J. Letter to the Editor: mRNA Vaccines in Urological Malignancies. Hum Gene Ther. 2022 Oct;33(19–20):1101–1102.
Journal cover image

Published In

Hum Gene Ther

DOI

EISSN

1557-7422

Publication Date

October 2022

Volume

33

Issue

19-20

Start / End Page

1101 / 1102

Location

United States

Related Subject Headings

  • mRNA Vaccines
  • Vaccines
  • Urologic Neoplasms
  • Immunotherapy
  • Humans
  • Biotechnology
  • 3206 Medical biotechnology
  • 1103 Clinical Sciences
  • 1004 Medical Biotechnology